全文获取类型
收费全文 | 79784篇 |
免费 | 5490篇 |
国内免费 | 1662篇 |
专业分类
耳鼻咽喉 | 3143篇 |
儿科学 | 918篇 |
妇产科学 | 1528篇 |
基础医学 | 2154篇 |
口腔科学 | 3283篇 |
临床医学 | 7358篇 |
内科学 | 7501篇 |
皮肤病学 | 717篇 |
神经病学 | 2679篇 |
特种医学 | 1362篇 |
外国民族医学 | 20篇 |
外科学 | 27560篇 |
综合类 | 10867篇 |
现状与发展 | 6篇 |
一般理论 | 2篇 |
预防医学 | 2991篇 |
眼科学 | 4703篇 |
药学 | 3441篇 |
170篇 | |
中国医学 | 894篇 |
肿瘤学 | 5639篇 |
出版年
2024年 | 263篇 |
2023年 | 2150篇 |
2022年 | 3334篇 |
2021年 | 4333篇 |
2020年 | 4264篇 |
2019年 | 3652篇 |
2018年 | 3485篇 |
2017年 | 3002篇 |
2016年 | 3012篇 |
2015年 | 3094篇 |
2014年 | 6097篇 |
2013年 | 5646篇 |
2012年 | 4595篇 |
2011年 | 4796篇 |
2010年 | 3794篇 |
2009年 | 3603篇 |
2008年 | 3433篇 |
2007年 | 3399篇 |
2006年 | 2958篇 |
2005年 | 2611篇 |
2004年 | 2271篇 |
2003年 | 1821篇 |
2002年 | 1440篇 |
2001年 | 1365篇 |
2000年 | 1172篇 |
1999年 | 1070篇 |
1998年 | 891篇 |
1997年 | 837篇 |
1996年 | 625篇 |
1995年 | 512篇 |
1994年 | 449篇 |
1993年 | 359篇 |
1992年 | 299篇 |
1991年 | 296篇 |
1990年 | 205篇 |
1989年 | 206篇 |
1988年 | 206篇 |
1987年 | 203篇 |
1986年 | 155篇 |
1985年 | 182篇 |
1984年 | 174篇 |
1983年 | 116篇 |
1982年 | 119篇 |
1981年 | 116篇 |
1980年 | 84篇 |
1979年 | 57篇 |
1978年 | 45篇 |
1977年 | 42篇 |
1976年 | 36篇 |
1975年 | 34篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
赵建刚 《中国中西医结合外科杂志》2020,26(3):452-456
目的:探讨右美托咪啶与芬太尼联合在ICU腹部外科术后机械通气患者中的应用效果及对镇静、镇痛作用的影响。方法:选择2018年5月—2019年6月ICU腹部外科术后机械通气患者62例,随机分为对照组(n=31例)和观察组(n=31例)。两组均采用芬太尼持续静脉泵入,对照组采用咪达唑仑镇静镇痛,观察组采用右美托咪啶镇静镇痛,比较两组镇痛镇静效果、镇静剂使用剂量、苏醒及达到镇静所需时间、血流动力学水平及安全性。结果:两组T2、T3时间点VAS评分分别为(2.40±0.31 vs 2.43±0.32和2.01±0.12 vs 2.05±0.15)、Ramsay量表评分分别(3.21±0.35 vs 3.20±0.33和3.01±0.25vs 3.00±0.24)均低于T1时间点(VAS评分2.94±0.69 vs 2.96±0.71;Ramsay量表评分3.57±0.61 vs 3.58±0.62)(P0.05);观察组右美托咪啶联合芬太尼镇痛镇静达到镇静所需时间(34.29±3.56) min长于对照组(23.63±3.21)(t=5.535,P=0.043);观察组镇静剂使用剂量(220.59±15.25)μg、苏醒时间(3.29±0.69)min均少(短)于对照组镇静剂使用剂量(386.44±18.92)μg、苏醒时间(7.56±1.21)min(t=6.294、6.092,P=0.023、0.025);两组T1、T2时间点心率[观察组T1(88.47±9.76)次/min、T2(86.41±9.43)次/min;对照组T1(89.53±10.41)次/min、T2(87.46±9.58)次/min]均高于T0时间点[观察组(78.78±4.35)次/min、对照组(79.12±4.41)次/min](P0.05);观察组T1、T2时间点MVP(79.58±5.71、87.53±6.76)mmHg高于对照组(74.12±4.69、75.26±5.61)mmHg(t=9.613、7.223,P=0.011、0.016);观察组的不良反应发生率为6.45%,与对照组的12.90%差异无统计学意义(χ~2=1.214, P=0.643)。结论:将右美托咪啶联合芬太尼用于ICU腹部外科术后机械通气患者中能获得良好的镇痛、镇静效果,缩短苏醒及达到镇静所需时间,血流动力学相对稳定,药物安全性较高,值得推广应用。 相似文献
24.
25.
Ciléin Kearns Nethmi Kearns Anna M. Paisley 《Journal of visual communication in medicine》2020,43(2):76-83
AbstractSupporting patients in making informed healthcare decisions is a cornerstone of ethical medical practice. Surgeons frequently draw for and show images to patients when consenting them for operations but the value of this practice in informed decision-making is unclear. An audit was conducted in a General Surgery Department. 244 patients completed questionnaires on the value of visual materials when giving consent for surgery. The complexity of the operations was classified into “simple”, “moderate” or “complex”. 100% of patients felt they had given informed consent to surgery. 62% of patients received at least one form of visual material during the consenting process. All patients who received a drawing, and 99% of those provided with other images, valued these resources. Visual materials were considered more useful to patients when giving consent for moderate or complex operations than simple ones. Approximately one third of patients who did not receive visual materials would have appreciated these when making an informed decision. This research highlights the value of surgeons drawing for, and providing other visual resources to, their patients as part of the consent process. There is a role for further research and training materials in drawing skills for surgeons. 相似文献
26.
27.
《Surgery for obesity and related diseases》2019,15(7):1219-1224
Endoscopic gastroplasty (EG) has been used in clinical practice to treat obesity. This systematic review has the objective of assessing if there is an acceptable level of scientific evidence on the safety and effectiveness of EG. A thorough search strategy was used up to October 2018, including the 2 most common techniques: endoscopic suturing and the primary obesity surgery endolumenal procedure. The quality of the studies was evaluated through the Joanna Briggs Institute Critical Appraisal tools for use in Systematic Reviews—“Checklist for Case Series”—and summarized using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach. Only 1 randomized controlled trial (moderate GRADE evidence) was found, and the remaining were case reports or small case series (very low GRADE evidence). The literature has low scientific quality. All studies, with 1 exception, are small case series with short follow-up. One of the randomized controlled trials did not meet the primary endpoint for weight loss in both groups (EG × sham) after 1-year follow-up. The case series reported from 16% to 19% total weight loss, but few had more than 6 months of follow-up. Serious adverse events ranged from 2% to 10%. Based on current literature, there is not enough quality scientific evidence regarding long-term weight loss and the procedure’s safety to recommend the use of EG in current clinical practice. 相似文献
28.
29.
30.